Skip to main content

Select Drug Profiles

Sleep, Practice Management

Healthcare Costs Among Patients with Excessive Sleepiness Associated with Obstructive Sleep Apnea, Shift Work Disorder, or Narcolepsy

Rashad Carlton, PharmD, MSPH, Cathryn A. Carroll, PhD, Orsolya Lunacsek, PhD, Timothy S. Regan, BPharm, RPh, CPh

Stakeholder Perspective

Out-of-Pocket Cost of Therapy Can Affect Patients’ Excessive Sleepiness and Daytime Functioning

by Teresa DeLuca, MD, MBA

Practice Management

Effects of Medicare Part D on Disparity Implications of Medication Therapy Management Eligibility Criteria

Marie Chisholm-Burns, PharmD, MPH, MBA, FCCP, FASHP, William C. Cushman, MD, Samuel Dagogo-Jack, MD, FRCP, JoEllen Jarrett Jamison, BS, Liyuan Li, PhD, Yanru Qiao, MS, Ya-Chen Tina Shih, PhD, Christina A. Spivey, PhD, Jim Y. Wan, PhD, Junling Wang, PhD, Shelley I. White-Means, PhD

Stakeholder Perspective

Medication Therapy Management, Medicare, and Disparities in Population Health

by Dima M. Qato, PharmD, MPH, PhD

Addressing an Unmet Need in the Treatment of Patients with Papulopustular Rosacea: An Interview with Dr Linda Stein Gold

Caroline Helwick

Investigational Agent Clears Papulopustular Rosacea by Tackling an Underlying Cause

Caroline Helwick

Practice Management

Lessons from the Leucovorin Shortages Between 2009 and 2012 in a Medicare Advantage Population: Where Do We Go from Here?

Mary S. Hayes, PharmD, S. Lane Slabaugh, PharmD, MBA, Melea A. Ward, PharmD, MS, Yihua Xu, PhD

Stakeholder Perspective

Drug Shortages Are Costly to Patients and to Payers

by Joseph P. Fuhr, Jr, PhD

Practice Management

Offering Lung Cancer Screening to High-Risk Medicare Beneficiaries Saves Lives and Is Cost-Effective: An Actuarial Analysis

Ellynne Dec, ASA, MAAA, Claudia I. Henschke, PhD, MD, David F. Yankelevitz, MD, Rowena Yip, MPH, Bruce S. Pyenson, FSA, MAAA

Stakeholder Perspective

Cost-Effectiveness and the Medicare Budget

by Joseph R. Antos, PhD

Original Research

Impact of Linaclotide Treatment on Work Productivity and Activity Impairment in Adults with Irritable Bowel Syndrome with Constipation: Results from 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

Jessica L. Buono, MPH, Robyn T. Carson, MPH, Jeffrey M. Johnston, MD, Phil Sarocco, RPh, MSc, Stavros Tourkodimitris, PhD

Stakeholder Perspective

Patient-Reported Outcomes Matter

by Walid F. Gellad, MD, MPH

Beyond Paternalism

David B. Nash, MD, MBA

Population Health and the Assessment of Value

Joseph D. Jackson, PhD

Stakeholder Integration Needed to Address a Flawed Reimbursement System

Matthew Mitchell, PharmD, MBA, FAMCP

Page 145 of 244
Results 1441 - 1450 of 2438